Opko Health (OPK) Liabilities and Shareholders Equity (2016 - 2025)
Opko Health's Liabilities and Shareholders Equity history spans 16 years, with the latest figure at $1.9 billion for Q4 2025.
- For Q4 2025, Liabilities and Shareholders Equity fell 12.19% year-over-year to $1.9 billion; the TTM value through Dec 2025 reached $8.0 billion, down 4.54%, while the annual FY2025 figure was $1.9 billion, 12.19% down from the prior year.
- Liabilities and Shareholders Equity reached $1.9 billion in Q4 2025 per OPK's latest filing, down from $2.0 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.5 billion in Q1 2021 to a low of $1.9 billion in Q4 2025.
- Average Liabilities and Shareholders Equity over 5 years is $2.2 billion, with a median of $2.2 billion recorded in 2022.
- Peak YoY movement for Liabilities and Shareholders Equity: increased 9.7% in 2024, then dropped 12.19% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $2.4 billion in 2021, then decreased by 9.69% to $2.2 billion in 2022, then decreased by 7.18% to $2.0 billion in 2023, then rose by 9.37% to $2.2 billion in 2024, then decreased by 12.19% to $1.9 billion in 2025.
- Per Business Quant, the three most recent readings for OPK's Liabilities and Shareholders Equity are $1.9 billion (Q4 2025), $2.0 billion (Q3 2025), and $2.0 billion (Q2 2025).